Overview
Iron overload is a disorder.
Treatments & Interventions
Clinical Trials
Recent Trials
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Research Evidence
Peer-reviewed studies linked via MeSH term "Iron Overload" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 60737008
- UMLS CUI
- C0282193
- Fully Specified Name
- Iron overload (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 2
- Clinical Trials
- 16
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.